1. 1322 Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. (September 2015) Authors: Kienle, D.; Winterhalder, R.; Koeberle, D.; Horber, D.; Kueng, M.; Saletti, P.; Helbling, D.; Bastian, S.; Dietrich, D.; Baertschi, D.; Pilop, C.; Von Moos, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1523 Bone Targeting Agent (BTA) treatment patterns and the impact of Bone Metastases (BMs) on advanced breast cancer patients in a real world setting. (September 2015) Authors: Von Moos, R.; Henry, D.; Body, J.J.; Rider, A.; De Courcy, J.; Murray, G.; Bhowmik, D.; Gatta, F.; Arellano, J.; Hechmati, G.; Qian, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1527 Bone Targeting Agent (BTA) treatment patterns and the impact of Bone Metastases (BM) on prostate cancer patients in a real world setting. (September 2015) Authors: Body, J.J.; Henry, D.; Von Moos, R.; Rider, A.; De Courcy, J.; Murray, G.; Bhowmik, D.; Gatta, F.; Arellano, J.; Hechmati, G.; Qian, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10). (September 2015) Authors: Pestalozzi, B.C.; Tausch, C.; Dedes, K.J.; Rochlitz, C.; Zimmermann, S.; Von Moos, R.; Winterhalder, R.C.; Ruhstaller, T.; Mueller, A.; Buser, K.S.; Borner, M.M.; Novak, U.; Uhlmann Nussbaum, C.; Seifert, B.; Bigler, M.; Bize, V.; Berardi Vilei, S.; Rageth, C.; Aebi, S.P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1971 A correlative study of Ki67 and two multigene RNA expression signatures in operable ER-positive postmenopausal breast cancer (SAKK 26/10). (September 2015) Authors: Jaggi, R.; Varga, Z.; Bigler, M.; Bize, V.; Bustamante Eduardo, M.; Berardi, S.; Chiesa, F.; Dedes, K.J.; Müller, A.; Tausch, C.; Vetter, M.; Von Moos, R.; Winterhalder, R.C.; Zimmermann, S.; Pestalozzi, B.; Aebi, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 316 Phase I study of lurbinectedin (PM01183) in combination with cisplatin (C) with or without aprepitant (Ap) in patients (pts) with advanced solid tumors. (September 2015) Authors: Forster, M.; Sessa, C.; Von Moos, R.; Brown, N.; Metaxas, Y.; Griguolo, G.; Lardelli, P.; Coronado, C.; Juan, L.; Fernandez-Teruel, C.; Soto-Matos, A.; Stathis, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase I study of lurbinectedin (PM01183) in combination with cisplatin (CDDP) with or without aprepitant in patients (pts) with advanced solid tumors. (February 2017) Authors: Forster, M.; Sessa, C.; Von Moos, R.; Brown, N.; Metaxas, Y.; Griguolo, G.; Lardelli, P.; Iglesias, J.; Fernandez-Teruel, C.; Jandali, U.; Soto-Matos, S.M.; Stathis, A. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗